ARTICLE | Clinical News
Fanapt iloperidone regulatory update
May 11, 2009 7:00 AM UTC
FDA approved an NDA from Vanda for Fanapt iloperidone to treat schizophrenia in adults. Vanda plans to launch the product later this year. Fanapt is a serotonin (5-HT2) receptor and dopamine receptor...